Processa pharmaceuticals announces closing of a $10.2 million private placement

Hanover, md, march 02, 2021 (globe newswire) -- processa pharmaceuticals, inc. (nasdaq: pcsa) is pleased to announce it has closed its previously announced private placement to institutional and accredited investors of $10.2 million. the company sold 1,321,132 shares of the common stock at a purchase price of $7.75 per share for $10.2 million in the private placement. the company received net proceeds of $9.9 million.
PCSA Ratings Summary
PCSA Quant Ranking